Synapse - Works

Results (5608)

Progression-free survival (PFS) as a new endpoint for designing phase II trials in patients with refractory germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Sunitinib (SU)-related hypertension in a randomized placebo (P)-controlled trial of GIST patients (pts)

Meeting Abstract

Ewer, M.; Suter, T. M.; Lenihan, D. J.; Niculescu, L.; Breazna, A.; Motzer, R. J.; Demetri, G. D.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase I trial of pulse-dose vorinostat with flavopiridol in solid tumors

Meeting Abstract

Dickson, M. A.; Rathkopf, D. E.; Grant, S.; Roberts, J. D.; Reid, J. M.; Ames, M. M.; McGovern, R. M.; Gonen, M.; Dials, H. J.; Schwartz, G. K.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Molecular profiling of circulating tumor cells (CTC) in patients with castrate metastatic prostate cancer (CMPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy

Meeting Abstract

Danila, D. C.; Anand, A.; Sung, C. C.; Leversha, M.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Molina, A.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase I pharmacokinetic (PK) and biodistribution study of radium-223 chloride in patients with castration resistant prostate cancer (CRPC) metastatic to bone

Meeting Abstract

Carrasquillo, J. A.; O'Donoghue, J. A.; Pandit-Taskar, N.; Rathkopf, D. E.; Aksnes, A.; Viner, C. L.; Hong, C. T.; Larson, S. M.; Scher, H. I.; Morris, M. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Antitumor activity of SNX-2112, a synthetic heat shock protein 90 inhibitor, in malignancies with amplification of the MET oncogene

Meeting Abstract

Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C.; Zeng, Z.; Viale, A.; Olshen, A.; Christensen, J. G.; Rosen, N.; Solit, D. B.; Weiser, M. R.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Correlation of the intra-tumor phospholipid-related signatures determined noninvasively by phosphorus and hydrogen MR spectroscopy: An approach to increase the sensitivity and applicability of the technique to predict therapeutic outcome in non-Hodgkin's lymphoma

Meeting Abstract

Arias-Mendoza, F.; Howe, F.; Griffiths, J. R.; Glickson, J. D.; O'Connor, O.; Koutcher, J. A.; Leach, M. O.; Heerschap, A.; Brown, T. R.; for the Cooperative Group of MR Applications in Cancer
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer (CRPC) treated with MDV3100

Meeting Abstract

Anand, A.; Scher, H. I.; Beer, T. M.; Higano, C. E.; Danila, D. C.; Taplin, M.; Efstathiou, E.; Hirmand, M.; Sawyers, C. L.; Heller, G.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

A randomized, double-blind, placebo-controlled phase III trial comparing docetaxel, prednisone, and placebo with docetaxel, prednisone, and bevacizumab in men with metastatic castration-resistant prostate cancer (mCRPC): Survival results of CALGB 90401

Meeting Abstract

Kelly, W. K.; Halabi, S.; Carducci, M. A.; George, D. J.; Mahoney, J. F.; Stadler, W. M.; Morris, M. J.; Kantoff, P. W.; Monk, J. P. 3rd; Small, E. J.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

PTEN and MDM2 inhibitors: Toward a novel pro-senescence therapy approach for patients with cancer

Meeting Abstract

Alimonti, A.; Nardella, C.; Pavese, I.; Clohessy, J. G.; Carracedo, A.; Trotman, L. C.; Woscholski, R.; Cognetti, F.; Scher, H. I.; Pandolfi, P.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save